Literature DB >> 10944451

Retinoblastoma protein phosphorylation via PI 3-kinase and mTOR pathway regulates adipocyte differentiation.

I Usui1, T Haruta, M Iwata, A Takano, T Uno, J Kawahara, E Ueno, T Sasaoka, M Kobayashi.   

Abstract

In the early phase of adipocyte differentiation, transient increase of DNA synthesis, called clonal expansion, and transient hyperphosphorylation of retinoblastoma protein (Rb) are observed. We investigated the role of these phenomena in insulin-induced adipocyte differentiation of 3T3-L1 cells. Insulin-induced clonal expansion, Rb phosphorylation and adipocyte differentiation were all inhibited by the PI 3-kinase inhibitors and rapamycin, but not the MEK inhibitor, whereas the MEK inhibitor, but not PI 3-kinase inhibitors or rapamycin, decreased c-fos induction. We conclude that insulin induces hyperphosphorylation of Rb via PI 3-kinase and mTOR dependent pathway, which promotes clonal expansion and adipocyte differentiation of 3T3-L1 cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944451     DOI: 10.1006/bbrc.2000.3201

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Signaling by target of rapamycin proteins in cell growth control.

Authors:  Ken Inoki; Hongjiao Ouyang; Yong Li; Kun-Liang Guan
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

2.  Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells.

Authors:  Weihua Yu; Zhenguang Chen; Jinli Zhang; Lirong Zhang; Hui Ke; Lihua Huang; Yanwen Peng; Xiuming Zhang; Shunong Li; Bruce T Lahn; Andy Peng Xiang
Journal:  Mol Cell Biochem       Date:  2007-12-02       Impact factor: 3.396

3.  Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation.

Authors:  H Miki; T Yamauchi; R Suzuki; K Komeda; A Tsuchida; N Kubota; Y Terauchi; J Kamon; Y Kaburagi; J Matsui; Y Akanuma; R Nagai; S Kimura; K Tobe; T Kadowaki
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

4.  Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes.

Authors:  Joshi Venugopal; Kazuhiko Hanashiro; Zhong-Zhou Yang; Yoshikuni Nagamine
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

Review 5.  The complexes of mammalian target of rapamycin.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

6.  Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.

Authors:  Isabelle Mercier; Jeanette Camacho; Kanani Titchen; Donna M Gonzales; Kevin Quann; Kelly G Bryant; Alexander Molchansky; Janet N Milliman; Diana Whitaker-Menezes; Federica Sotgia; Jean-François Jasmin; Roland Schwarting; Richard G Pestell; Mikhail V Blagosklonny; Michael P Lisanti
Journal:  Am J Pathol       Date:  2012-06-13       Impact factor: 4.307

7.  Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancer.

Authors:  Robert C Bast; Gordon B Mills
Journal:  Cancer Discov       Date:  2012-01       Impact factor: 39.397

Review 8.  The mTOR signalling pathway in human cancer.

Authors:  Helena Pópulo; José Manuel Lopes; Paula Soares
Journal:  Int J Mol Sci       Date:  2012-02-10       Impact factor: 6.208

Review 9.  The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.

Authors:  Emilio Russo; Rita Citraro; Andrew Constanti; Giovambattista De Sarro
Journal:  Mol Neurobiol       Date:  2012-07-24       Impact factor: 5.682

Review 10.  PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franziska Briest; Patricia Grabowski
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.